Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5621
Gene Symbol: PRNP
PRNP
0.030 GeneticVariation group BEFREE Mice containing murine prion protein transgenes with this mutation spontaneously develop neurologic symptoms of ataxia, lethargy, and rigidity accompanied by spongiform degeneration throughout the brain. 1685324 1991
Entrez Id: 84735
Gene Symbol: CNDP1
CNDP1
0.300 Biomarker group CTD_human Histopathology of the nervous system in carnosinase enzyme deficiency with mental retardation. 4673339 1972
Entrez Id: 1727
Gene Symbol: CYB5R3
CYB5R3
0.010 AlteredExpression group BEFREE NADH-cytochrome b5 reductase in platelets and leukocytes with special reference to normal levels and to levels in carriers of hereditary methemoglobinemia with or without neurological symptoms. 6768212 1980
Entrez Id: 1993
Gene Symbol: ELAVL2
ELAVL2
0.010 Biomarker group BEFREE No differences were identified regarding the reactivity of the anti-Hu antibodies with HuD, HuC, and Hel-N1 and the spectrum of neurological symptoms presented by the patients. 7541976 1995
Entrez Id: 5973
Gene Symbol: RENBP
RENBP
0.010 Biomarker group BEFREE Patients can present at a young age, generally with symptoms of liver copper intoxication, or later on, generally with neurological symptoms. 7666402 1995
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.030 Biomarker group BEFREE Ataxia with vitamin E deficiency (AVED) is an autosomal recessive disease characterized clinically by neurological symptoms with often striking resemblance to those of Friedreich ataxia. 7726167 1995
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.070 GeneticVariation group BEFREE We conclude that the observed neurological symptoms are unrelated to the ASA genotype and that PD/MLD compound heterozygotes are not at an increased risk for developing progressive nervous system diseases. 8095368 1993
Entrez Id: 7167
Gene Symbol: TPI1
TPI1
0.030 GeneticVariation group BEFREE Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms. 8244340 1993
Entrez Id: 3700
Gene Symbol: ITIH4
ITIH4
0.010 Biomarker group BEFREE The neurotoxin-like sequence of human immunodeficiency virus gp120: a comparison of sequence data from patients with and without neurological symptoms. 8470367 1993
Entrez Id: 6647
Gene Symbol: SOD1
SOD1
0.040 GeneticVariation group BEFREE Since childbearing is usually accomplished well before the onset of neurological symptoms in ALS, and since reduced fecundity was found in male ALS gene-carriers, these findings raise the possibility that an ALS gene might have a pleiotrophic effect on fertility in males occurring decades before the onset of neurological symptoms. 8588576 1995
Entrez Id: 3483
Gene Symbol: IGFALS
IGFALS
0.010 GeneticVariation group BEFREE Since childbearing is usually accomplished well before the onset of neurological symptoms in ALS, and since reduced fecundity was found in male ALS gene-carriers, these findings raise the possibility that an ALS gene might have a pleiotrophic effect on fertility in males occurring decades before the onset of neurological symptoms. 8588576 1995
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.070 GeneticVariation group BEFREE Analysis of the two PD mutations in the ASA gene separately was carried out in a large group of subjects with neurological symptoms and low ASA activity, including close relatives and MLD patients. 8750609 1995
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.070 AlteredExpression group BEFREE Out of 8 cases with neurological symptoms and low ASA activity, 2 were found to be homozygous for the Pd allele; 2 MLD patients had healthy siblings homozygous for the Pd allele and another patient's allele bore two mutations, Pd and that causing MLD. 8946177 1996
Entrez Id: 5860
Gene Symbol: QDPR
QDPR
0.030 GeneticVariation group BEFREE Mutations in the dihydropteridine reductase (DHPR) gene result in hyperphenylalaninaemia and deficiency of various neurotransmitters in the central nervous system, causing severe neurological symptoms. 9341885 1997
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.070 GeneticVariation group BEFREE A 9-bp deletion (2320del9) on the background of the arylsulfatase A pseudodeficiency allele in a metachromatic leukodystrophy patient and in a patient with nonprogressive neurological symptoms. 9490297 1998
Entrez Id: 928
Gene Symbol: CD9
CD9
0.010 Biomarker group BEFREE Histopathological and immunohistochemical examination of the brain for HIV-1 p24 antigen was performed in 50 HIV-infected patients with neurological symptoms; patients were defined as having HIV encephalitis in the presence of HIV-related lesions or HIV-1 p24 antigen-positive cells. 9520168 1998
Entrez Id: 11261
Gene Symbol: CHP1
CHP1
0.010 Biomarker group BEFREE Histopathological and immunohistochemical examination of the brain for HIV-1 p24 antigen was performed in 50 HIV-infected patients with neurological symptoms; patients were defined as having HIV encephalitis in the presence of HIV-related lesions or HIV-1 p24 antigen-positive cells. 9520168 1998
Entrez Id: 11076
Gene Symbol: TPPP
TPPP
0.010 Biomarker group BEFREE Histopathological and immunohistochemical examination of the brain for HIV-1 p24 antigen was performed in 50 HIV-infected patients with neurological symptoms; patients were defined as having HIV encephalitis in the presence of HIV-related lesions or HIV-1 p24 antigen-positive cells. 9520168 1998
Entrez Id: 140767
Gene Symbol: NRSN1
NRSN1
0.010 Biomarker group BEFREE Histopathological and immunohistochemical examination of the brain for HIV-1 p24 antigen was performed in 50 HIV-infected patients with neurological symptoms; patients were defined as having HIV encephalitis in the presence of HIV-related lesions or HIV-1 p24 antigen-positive cells. 9520168 1998
Entrez Id: 10959
Gene Symbol: TMED2
TMED2
0.010 Biomarker group BEFREE Histopathological and immunohistochemical examination of the brain for HIV-1 p24 antigen was performed in 50 HIV-infected patients with neurological symptoms; patients were defined as having HIV encephalitis in the presence of HIV-related lesions or HIV-1 p24 antigen-positive cells. 9520168 1998
Entrez Id: 115482709
Gene Symbol: H3P19
H3P19
0.010 Biomarker group BEFREE Histopathological and immunohistochemical examination of the brain for HIV-1 p24 antigen was performed in 50 HIV-infected patients with neurological symptoms; patients were defined as having HIV encephalitis in the presence of HIV-related lesions or HIV-1 p24 antigen-positive cells. 9520168 1998
Entrez Id: 1356
Gene Symbol: CP
CP
0.070 AlteredExpression group BEFREE The presence of neurologic symptoms in aceruloplasminemia is unique among the known inherited and acquired disorders of iron metabolism; recent studies revealed an essential role for astrocyte-specific expression of ceruloplasmin in iron metabolism and neuronal survival in the central nervous system. 9587138 1998
Entrez Id: 2639
Gene Symbol: GCDH
GCDH
0.010 GeneticVariation group BEFREE Glutaric acidemia type I (GAI) (McKusick 231670) is an autosomal recessive disease affecting the catabolism of the amino acids lysine, hydroxylysine and tryptophan, caused by a defect in the gene encoding glutaryl-coenzyme A dehydrogenase (GCDH) and associated with severe neurological symptoms. 9600243 1998
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.010 AlteredExpression group BEFREE CSF levels of MCP-1 were determined in 37 HIV-infected patients with neurological symptoms, and were compared with both the presence and severity of HIV-1 encephalitis at post-mortem examination and CSF HIV RNA levels. 9708412 1998
Entrez Id: 1356
Gene Symbol: CP
CP
0.070 Biomarker group BEFREE The presence of neurologic symptoms in patients with aceruloplasminemia is unique among the characterized disorders of iron metabolism, and recent findings indicate that astrocyte-specific ceruloplasmin gene expression is critical for iron metabolism and neuronal survival in the retina and basal ganglia. 9727700 1998